Serveur d'exploration sur la visibilité du Havre

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Haemodialysis of pyrazinamide in uraemic patients

Identifieur interne : 001601 ( France/Analysis ); précédent : 001600; suivant : 001602

Haemodialysis of pyrazinamide in uraemic patients

Auteurs : C. Lacroix [France] ; A. Hermelin [France] ; R. Guiberteau [France] ; C. Guyonnaud [France] ; J. Nouveau [France] ; H. Duwoos [France] ; O. Lafont [France]

Source :

RBID : ISTEX:B727ECFFFAE073551F411AEA83F18F3A11ABF76C

English descriptors

Abstract

Summary: The pharmacokinetics of PZA during haemodialysis were determined in 6 patients with chronic renal impairment after a single oral dose of 25.7 (1.9) mg·kg−1. The dialysis clearance of PZA and of its metabolites were: pyrazinamide 132 ml·min−1; pyrazinoic acid 121 ml·min−1; 5-hydroxy-pyrazinamide 107 ml·min−1; 5-hydroxy-pyrazinoic acid 118 ml·min−1. The average amount extracted during a dialysis session of 4.1 h was 926 mg after an oral dose of 1700 mg. The high dialysability shows that PZA can property be administered at the end of each dialysis session in the usual dose of 25 to 30 mg·kg−1.

Url:
DOI: 10.1007/BF00679791


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:B727ECFFFAE073551F411AEA83F18F3A11ABF76C

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Haemodialysis of pyrazinamide in uraemic patients</title>
<author>
<name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C." last="Lacroix">C. Lacroix</name>
</author>
<author>
<name sortKey="Hermelin, A" sort="Hermelin, A" uniqKey="Hermelin A" first="A." last="Hermelin">A. Hermelin</name>
</author>
<author>
<name sortKey="Guiberteau, R" sort="Guiberteau, R" uniqKey="Guiberteau R" first="R." last="Guiberteau">R. Guiberteau</name>
</author>
<author>
<name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
</author>
<author>
<name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
</author>
<author>
<name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
</author>
<author>
<name sortKey="Lafont, O" sort="Lafont, O" uniqKey="Lafont O" first="O." last="Lafont">O. Lafont</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B727ECFFFAE073551F411AEA83F18F3A11ABF76C</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1007/BF00679791</idno>
<idno type="url">https://api.istex.fr/document/B727ECFFFAE073551F411AEA83F18F3A11ABF76C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000180</idno>
<idno type="wicri:Area/Istex/Curation">000180</idno>
<idno type="wicri:Area/Istex/Checkpoint">001289</idno>
<idno type="wicri:doubleKey">0031-6970:1989:Lacroix C:haemodialysis:of:pyrazinamide</idno>
<idno type="wicri:Area/Main/Merge">002719</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2612545</idno>
<idno type="wicri:Area/PubMed/Corpus">000449</idno>
<idno type="wicri:Area/PubMed/Curation">000449</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000449</idno>
<idno type="wicri:Area/Ncbi/Merge">000484</idno>
<idno type="wicri:Area/Ncbi/Curation">000484</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000484</idno>
<idno type="wicri:doubleKey">0031-6970:1989:Lacroix C:haemodialysis:of:pyrazinamide</idno>
<idno type="wicri:Area/Main/Merge">002666</idno>
<idno type="wicri:Area/Main/Curation">002646</idno>
<idno type="wicri:Area/Main/Exploration">002646</idno>
<idno type="wicri:Area/France/Extraction">001601</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Haemodialysis of pyrazinamide in uraemic patients</title>
<author>
<name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C." last="Lacroix">C. Lacroix</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hermelin, A" sort="Hermelin, A" uniqKey="Hermelin A" first="A." last="Hermelin">A. Hermelin</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Guiberteau, R" sort="Guiberteau, R" uniqKey="Guiberteau R" first="R." last="Guiberteau">R. Guiberteau</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lafont, O" sort="Lafont, O" uniqKey="Lafont O" first="O." last="Lafont">O. Lafont</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Chimie Organique, Centre de Pharmacochimie du Madrillet, Faculté de Médecine et de Pharmacie de Rouen, Saint-Etienne du Rouvray</wicri:regionArea>
<wicri:noRegion>Saint-Etienne du Rouvray</wicri:noRegion>
<wicri:noRegion>Saint-Etienne du Rouvray</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">European Journal of Clinical Pharmacology</title>
<title level="j" type="abbrev">Eur J Clin Pharmacol</title>
<idno type="ISSN">0031-6970</idno>
<idno type="eISSN">1432-1041</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="1989-05-01">1989-05-01</date>
<biblScope unit="volume">37</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="309">309</biblScope>
<biblScope unit="page" to="311">311</biblScope>
</imprint>
<idno type="ISSN">0031-6970</idno>
</series>
<idno type="istex">B727ECFFFAE073551F411AEA83F18F3A11ABF76C</idno>
<idno type="DOI">10.1007/BF00679791</idno>
<idno type="ArticleID">BF00679791</idno>
<idno type="ArticleID">Art20</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0031-6970</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Biotransformation</term>
<term>Chromatography, High Pressure Liquid</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Pyrazinamide (blood)</term>
<term>Pyrazinamide (metabolism)</term>
<term>Pyrazinamide (pharmacokinetics)</term>
<term>Renal Dialysis</term>
<term>Uremia (blood)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Pyrazinamide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Pyrazinamide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Pyrazinamide</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Uremia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Biotransformation</term>
<term>Chromatography, High Pressure Liquid</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Renal Dialysis</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Summary: The pharmacokinetics of PZA during haemodialysis were determined in 6 patients with chronic renal impairment after a single oral dose of 25.7 (1.9) mg·kg−1. The dialysis clearance of PZA and of its metabolites were: pyrazinamide 132 ml·min−1; pyrazinoic acid 121 ml·min−1; 5-hydroxy-pyrazinamide 107 ml·min−1; 5-hydroxy-pyrazinoic acid 118 ml·min−1. The average amount extracted during a dialysis session of 4.1 h was 926 mg after an oral dose of 1700 mg. The high dialysability shows that PZA can property be administered at the end of each dialysis session in the usual dose of 25 to 30 mg·kg−1.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<settlement>
<li>Le Havre</li>
</settlement>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C." last="Lacroix">C. Lacroix</name>
</noRegion>
<name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
<name sortKey="Guiberteau, R" sort="Guiberteau, R" uniqKey="Guiberteau R" first="R." last="Guiberteau">R. Guiberteau</name>
<name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
<name sortKey="Hermelin, A" sort="Hermelin, A" uniqKey="Hermelin A" first="A." last="Hermelin">A. Hermelin</name>
<name sortKey="Lafont, O" sort="Lafont, O" uniqKey="Lafont O" first="O." last="Lafont">O. Lafont</name>
<name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001601 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 001601 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/France
   |area=    LeHavreV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:B727ECFFFAE073551F411AEA83F18F3A11ABF76C
   |texte=   Haemodialysis of pyrazinamide in uraemic patients
}}

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 14:37:02 2016. Site generation: Tue Mar 5 08:25:07 2024